Search

Your search keyword '"Targeted drugs"' showing total 62 results

Search Constraints

Start Over You searched for: Descriptor "Targeted drugs" Remove constraint Descriptor: "Targeted drugs" Topic medicine Remove constraint Topic: medicine
62 results on '"Targeted drugs"'

Search Results

1. Advances in current research on the immunopathogenesis of Sjögren’s syndrome and targeted therapeutic strategies

2. Analysis of two-gene signatures and related drugs in small-cell lung cancer by bioinformatics

3. Comparative tolerability of targeted therapies in pulmonary hypertension

4. Clinical efficacy, safety, tolerability, and survival outcome of long-term inhaled iloprost treatment in the management of pulmonary arterial hypertension: Data from prospective multicenter observational OPTION study

5. B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection

6. Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation

7. Identification of Potential BRAF Inhibitor Joint Therapy Targets in PTC based on WGCAN and DCGA

8. Variation of Cost among Anti-cancer Drugs Available in Indian Market

9. METHODOLOGICAL APPROACHES TO THE DETERMINATION OF CHEMORESISTANCE OF HUMAN CANCER CELLS TO ANTI-CANCER DRUGS

10. Anti-Tumour Drugs: Planning Preclinical Efficacy and Safety Studies

11. Features of pathogenesis and treatment of breast cancer in the works of modern oncologists

12. Trends in survival and costs in metastatic melanoma in the era of novel targeted and immunotherapeutic drugs

13. Mitochondria-Shaping Proteins and Chemotherapy

14. STARD3: A Prospective Target for Cancer Therapy

15. New approaches and procedures for cancer treatment: Current perspectives

16. Inhibition of p53 inhibitors: progress, challenges and perspectives

17. Pituitary Adenomas: What Are the Key Features? What Are the Current Treatments? Where Is the Future Taking Us?

18. Understanding Apoptosis and Apoptotic Pathways Targeted Cancer Therapeutics

19. Novel Poly-(Lactic-Co-Glycolic Acid) Targeted Nanoparticles Conjunct with Antibody for the Enhancement of Antibacterial Activity against Ralstonia solanacearum

20. The Challenges of Precision Oncology Drug Development and Implementation.

21. Drug Combination in Cancer Treatment-From Cocktails to Conjugated Combinations

22. Severe infections in patients with lymphoproliferative diseases treated with new targeted drugs: A multicentric real-world study

23. The Research Progress of Direct KRAS G12C Mutation Inhibitors

24. Function of p21 and its therapeutic effects in esophageal cancer

25. Transcatheter closure for patent ductus arteriosus in patients with Eisenmenger syndrome: to do or not?

26. Cisplatin Resistance in Osteosarcoma: In vitro Validation of Candidate DNA Repair-Related Therapeutic Targets and Drugs for Tailored Treatments

27. Overview of epstein–barr-virus-associated gastric cancer correlated with prognostic classification and development of therapeutic options

28. Systematic target actionability reviews of preclinical proof-of-concept papers to match targeted drugs to paediatric cancers

29. Novel treatments for anaplastic thyroid carcinoma

30. New therapeutic agents for metastatic colorectal cancer: literature review

31. CLINICAL CASES OF THE EFFICACY OF THERAPY MULTIKINASE INHIBITORS OF METASTATIC RADIOID-REFRACTORY DIFFERENTIATED THYROID CANCER

32. Autoimmune Hemolytic Anemia in Chronic Lymphocytic Leukemia: A Comprehensive Review

33. Effect of cancer drugs in patients with metastatic colorectal cancer in terms of mortality reduction

34. Organotypic three-dimensional cancer cell cultures mirror drug responses in vivo: lessons learned from the inhibition of EGFR signaling

35. Novel treatment concepts in Hodgkin lymphoma

36. How to use ibrutinib

37. Production of a SCID mouse model of medulloblastoma to explore the therapeutic value of targeting tumor driver genes

38. Recent advances in precision medicine for the treatment of anaplastic thyroid cancer

39. Next-Generation Sequencing Identifies Potential Actionable Targets in Paediatric Sarcomas

40. Oncology drug-companion diagnostic combinations

41. The relevance of using 3D cell cultures, in addition to 2D monolayer cultures, when evaluating breast cancer drug sensitivity and resistance

42. METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY

43. Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?

44. Funds Reimbursement of High-Cost Drugs in Gastrointestinal Oncology: An Italian Real Practice 1 Year Experience at the National Cancer Institute of Naples

45. Stranski učinki ob zdravljenju rakavih bolezni z zaviralci tirozinskih kinaz

46. Testing biologics and intracellular signaling inhibitors on pediatric atopic dermatitis: a stairway to modern therapeutic approaches

47. Are predictions of cancer response to targeted drugs, based on effects in unrelated tissues, the ‘Black Swan’ events?

48. Midostaurin: a magic bullet that blocks mast cell expansion and activation

49. Targeted drugs for pulmonary arterial hypertension: a network meta-analysis of 32 randomized clinical trials

50. Novel treatment options for anaplastic thyroid cancer

Catalog

Books, media, physical & digital resources